BIOCHEMICAL SOCIETY TRANSACTIONS
Foetal membranes and attached decidua Vera were removed from placentae collected at the time of elective caesarean section performed before the onset of labour. The tissues were washed twice in ice-cold 0.15 M-NaCI. The amnion tissue was peeled away from the chorion laeve, and the decidua Vera was removed from the chorion laeve by scraping. A portion of the villous tissue of placenta was cut from the maternal surface. Specimens of each tissue were homogenized in ice-cold 50 m~~p h o s p h a t e buffer, pH7.4 (buffer:tissue ratio, 1 :3 w/v), with a Polytron PTlO homogenizer at a setting of 6 for 30s. Each hornogenate was successively centrifuged at lOOOg for 20min and 105000g for 1 h. The resulting supernatant fraction (cytosol) was used for tests on prostaglandin synthesis. To obtain boiled cytosol, a small portion of each cytosol was boiled for 3min and centrifuged at 2000g for 30min to remove denatured proteins. Experiments were conducted with arachidonic acid and bovine seminal-vesicle prostaglandin synthase (Miles Laboratories, Elkhart, IN, U.S.A.). The incubation mixture consisted of 4mg of synthase in 1.0ml of 50m~-phosphate buffer, pH 7.4, with or without test cytosol. The reaction was started by addition of sodium arachidonate (final concn. 6 1 p~) , and the tubes were aerated with gentle shaking. After 20min, the reaction was stopped by adding 0. 51111 of 0.4M-citric acid, and the mixture was extracted with 7.0ml of ethyl acetate. The organic layer was removed, evaporated to dryness under N, and the residue dissolved in 1.0mI of phosphate buffer. Prostaglandin E,, prostaglandin F,, and 6-oxoprostaglandin F a metabolite of prostacyclin, were measured by specific radioimmunoassays (Mitchell & Flint, 1978; Mitchell, 1978) . The results obtained with various cytosols (boiled and unboiled) tested both at low and high concentration for the stimulation of prostaglandin synthase system of bovine seminal vesicles are summarized in Table 1 . It is evident that the presence of unboiled cytosol in the reaction mixture enhanced the production of prostaglandins, especially that of prostaglandin F,, and 6-oxoprostaglandin F,a. This effect of the cytosol was dose-dependent and sensitive to boiling. Among the cytosols of various intrauterine tissues, placental cytosol produced a much larger stimulatory effect on prostaglandin F,, and 6-oxoprostaglandin F,, biosynthesis than did the cytosols derived from amnion, chorion laeve and decidua Vera. It also is noteworthy that, except for placenta, none of the other tissue cytosols affected prostaglandin E, synthesis. The capacity of each cytosol to stimulate prostaglandin biosynthesis also was found to be completely abolished by indomethacin. These results therefore point to the existence of a highly specialized mechanism for modulating prostaglandin F,, and prostacyclin production in human intra-uterine tissue.
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Embrey, M. P. As part of a programme to investigate the possible role of human endogenous inhibitors in the regulation of prostaglandin biosynthesis during pregnancy and parturition, we studied the effect of human amniotic fluid and pregnancy plasma on the biosynthesis of various prostaglandins. Experiments were performed with arachidonic acid and bovine seminal-vesicle prostaglandin synthase (Miles Laboratories, Elkhart, IN, U.S.A.). The standard assay mixture contained, in a final volume of I.Oml, 50m~-phosphate buffer, pH 7.4, reduced glutathione (1.3 mM), with and without test fluid, 4 mg of prostaglandin synthase and sodium arachidonate (61pm). After 20min incubation with gentle shaking at 37OC, the reaction was stopped by adding 0.5 ml of 0.4 M-CitriC acid, and the prostaglandins were extracted with 7.0ml of ethyl acetate. After thorough mixing and centrifugation for 5min at 600g the ethyl acetate layer was removed, evaporated to dryness under N, and the residue dissolved in 1.0ml of phosphate buffer, pH 7.4. Prostaglandin E, and 6-oxoprostaglandin F ,a were measured by specific radioimmunoassays (Mitchell & Flint, 1978; Mitchell, 1978 ) that have been fully described and validated. All experiments were performed with appropriate controls.
The concentration-dependent degrees of inhibition of prostaglandin biosynthesis by human amniotic fluid, plasmas of pregnant and non-pregnant women and indomethacin are presented in Table 1 . It is evident that amniotic fluid, in common with plasma of pregnant women, inhibited prostaglandin biosynthesis. The inhibitory effects of amniotic fluid were more pronounced against the synthesis of prostaglandin E, than that of 6-oxoprostaglandin FIa. Plasmas from pregnant and nonpregnant women inhibited prostaglandin synthesis strikingly. This effect of plasma was abolished by heating at 100°C for 5 min and was associated with a protein.
In preliminary experiments designed to investigate the nature of the proteins with endogenous inhibitor activity, the plasma of pregnant women was fractionated by continuous sucrosedensity-gradient ultracentrifugation (Beckman model L265, rotor SW60; 200000g for 19h at 4°C). The results of this analysis indicated that the endogenous inhibitor activity of pregnancy plasma was mainly associated with protein fractions sedimenting in the region of 4 S and 5 S of the gradient. Further purification of these proteins is required to establish the presence of a pregnancy-associated endogenous inhibitor of prostaglandin synthase in humans.
These results demonstrate the presence of endogenous inhibitor activity in amniotic fluid and pregnancy plasma. Since albumin is the major protein found in the amniotic fluid and because albumin has been shown previously to inhibit prostaglandin E, biosynthesis, the question remains: by what mechanism does albumin inhibit prostaglandin biosynthesis? Since albumin does not affect fatty acid cyclo-oxygenase (Collier et al., 1982) , we speculate that albumin could inhibit prostaglandin production either (i) by binding to the fatty acid substrate or (ii) by enhancing uptake of arachidonic acid into glycerophospholipids and triacylglycerols. The latter proposition is supported further by our recent finding (S. A. Saeed & M. D. Mitchell, unpublished work) that a cytosolic factor in human amnion enhances incorporation of arachidonate into lipids during incubation with a microsomal fraction from human amnion.
